HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90 | -91.0% | 1 | -87.5% | 0.00% | – |
| Q1 2021 | $1,000 | -97.6% | 8 | -97.7% | 0.00% | – |
| Q4 2020 | $42,000 | +35.5% | 351 | 0.0% | 0.00% | – |
| Q3 2020 | $31,000 | 0.0% | 351 | +0.3% | 0.00% | – |
| Q2 2020 | $31,000 | +3000.0% | 350 | +4275.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 8 | -42.9% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -60.0% | 14 | -63.2% | 0.00% | – |
| Q2 2019 | $5,000 | +150.0% | 38 | +40.7% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 27 | -10.0% | 0.00% | – |
| Q4 2018 | $3,000 | -50.0% | 30 | -38.8% | 0.00% | – |
| Q3 2018 | $6,000 | +20.0% | 49 | -12.5% | 0.00% | – |
| Q2 2018 | $5,000 | +25.0% | 56 | -3.4% | 0.00% | – |
| Q1 2018 | $4,000 | -20.0% | 58 | -30.1% | 0.00% | – |
| Q4 2017 | $5,000 | – | 83 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |